Socio-psychological Factors Involved in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies — Psy-Greffe  

Leukemia Clinical Trial

Official title: Study of the Role of Socio-psychological Factors in the Hematopoietic Stem Cell Transplantation Process in People With Hemopathies

Status Completed

Clinical Trial Summary

Identify the psychological factors (i.e. personality and transactional factors), beneficial and deleterious, at different phases of the transplant process, on the patient's mental health (quality of life, short and long-term post-transplant recovery) and physical health (e.g. infections, relapse, length of hospitalization or even death).

Clinical Trial Description

To reach the research purposes, questionnaires will be given to patients at different times during the transplant process : 1. Pre-admission transplant questionnaire: given and collected by the transplant physician during the pre-graft consultation before entering hospitalization (approximatively 15 days before). To be completed by the patient on site (approximately 45 minutes to complete the questionnaire) 2. Transplant admission questionnaire: given during the first days of hospitalization. To be completed within 6 days and returned to the transplant physician (approximately 30 minutes to complete the questionnaire) 3. Post-transplant follow-up questionnaire: given in consultation at 6 months by the transplant physician (between 30 and 45 minutes to complete the questionnaire in consultation) The questionnaires include validated and standardized scales. The first questionnaire contains scales on dispositional factors (i.e. personality factors) . The second one is on the so-called transactional adjustment factors. And the third is on post-transplant factors (e. g. post-traumatic growth). Scales from the first and second questionnaire will be used to obtain a longitudinal view. The study population concerns all patients going to receive an allograft transplantation, aged over 18 years, who have consented to answer the various questionnaires over a period of approximately 7 months . The participants come from the hematology departments of the Saint-Louis Hospital in Paris, the Estaing University Hospital in Clermont-Ferrand and the Brabois Hospital in Nancy. ;

Related Conditions & MeSH terms

• Leukemia

• NCT number: NCT03883672
• Study type: Interventional
• Source: Saint-Louis Hospital, Paris, France
• Status: Completed
• Phase: N/A
• Start date: November 10, 2017
• Completion date: September 12, 2020